missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human FoxO1/FKHR Antibody, R&D Systems™

Mouse Monoclonal Antibody
Brand: R&D Systems MAB5939-SP
This item is not returnable.
View return policy
Description
FoxO1/FKHR Monoclonal specifically detects FoxO1/FKHR in Human samples. It is validated for Immunocytochemistry.
Specifications
| FoxO1/FKHR | |
| Monoclonal | |
| LYOPH | |
| Immunocytochemistry 5-25 ug/mL | |
| Q12778 | |
| FOXO1 | |
| E. coli- derived recombinant human FoxO1/FKHR Ala353-Gly655 Accession # Q12778 | |
| 25 μg | |
| Primary | |
| Detects human FoxO1/FKHR in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant human FoxA1 (aa 253-472), B1 (aa 191-324), C1 (aa 208-322), D3 (aa 1-140), F1 (aa 129-354), G1 (aa 283-489), J1 (aa 301-421), J3 (aa 375-552), K1 (aa 493-670), M1 (aa 642-763), O3A (aa 372-673), P1 (aa 231-420), P2 (aa 269-460), P3 (aa 179-279), or P4 (aa 229-410) is observed. | |
| Human | |
| Purified |
| Immunocytochemistry | |
| 597554 | |
| Unconjugated | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
| FKH1, FKHR, FKHRforkhead box protein O1, forkhead box O1, Forkhead box protein O1A, forkhead homolog in rhabdomyosarcoma, Forkhead in rhabdomyosarcoma, FOXO1Aforkhead, Drosophila, homolog of, in rhabdomyosarcoma | |
| Mouse | |
| Protein A or G purified from hybridoma culture supernatant | |
| RUO | |
| 2308 | |
| Sterile PBS to a final concentration of 0.5 mg/mL. | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. | |
| IgG2b |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction